Age, Biography and Wiki

Jeffrey Aronson (Jeffrey Kenneth Aronson) was born on 1947, is an A fellow of the Royal College of Physicians. Discover Jeffrey Aronson's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 77 years old?

Popular As Jeffrey Kenneth Aronson
Occupation N/A
Age 77 years old
Zodiac Sign
Born 1947
Birthday 1947
Birthplace N/A
Nationality United Kingdom

We recommend you to check the complete list of Famous People born on 1947. He is a member of famous with the age 77 years old group.

Jeffrey Aronson Height, Weight & Measurements

At 77 years old, Jeffrey Aronson height not available right now. We will update Jeffrey Aronson's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Jeffrey Aronson Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Jeffrey Aronson worth at the age of 77 years old? Jeffrey Aronson’s income source is mostly from being a successful . He is from United Kingdom. We have estimated Jeffrey Aronson's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Jeffrey Aronson Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

1947

Jeffrey Kenneth Aronson (born 1947) is a British clinical pharmacologist.

1964

Aronson studied at the University of Glasgow from 1964 to 1970, qualifying with the degree of MBChB, and after primary medical training in Glasgow hospitals (MRCP 1973) joined the Medical Research Council's Unit and University Department of Clinical Pharmacology in Oxford, qualifying DPhil Oxon in 1977.

1980

After further clinical and scientific training, in 1980 he became Wellcome Lecturer and Consultant in Clinical Pharmacology and later Reader in Clinical Pharmacology at the University of Oxford and an honorary consultant physician in the Oxford Radcliffe Hospitals Trust until 2014.

He now works as an Honorary Consultant Physician and Clinical Pharmacologist in the Centre for Evidence Based Medicine in the Nuffield Department of Primary Care Health Sciences in Oxford.

1985

He was elected a Fellow of the Royal College of Physicians in 1985, an Honorary Fellow of the Faculty of Pharmaceutical Medicine in 2007, and an Honorary Fellow of the British Pharmacological Society in 2014.

He has published over 200 original scientific papers and over 300 reviews and editorial reviews in peer-reviewed bioscience journals.

He publishes a weekly opinion column in the BMJ under the general heading "When I Use a Word".

1997

Starting in 1997, he edited volumes 20-35 of the Side Effects of Drugs Annual.

2006

He also served as chair of the British Pharmacopoeia Commission's Expert Advisory Group on Nomenclature from 2006 to 2021 and currently chairs its successor committee, the Joint Expert Advisory Groups on Pharmacy and Nomenclature.

He is a member of the World Health Organization’s Expert Advisory Panel on International Pharmacopoeia and Pharmaceutical Preparations.

He was a member of the Formulary Committees of the British National Formulary from 2006 to 2012, and of the British National Formulary for Children from 2003 to 2012

He edited the 15th and 16th editions (Elsevier, 2006 and 2016) of Meyler’s Side Effects of Drugs—The International Encyclopedia of Adverse Drug Reactions and Interactions.

2008

He served as president of the British Pharmacological Society in 2008-2009; as vice-chairman of the Medicines Commission from 2002 to 2005; and as editor-in-chief of the British Journal of Clinical Pharmacology from 2002 to 2007.

2011

Together with John Talbot, he edited the 6th edition of Stephens’ Detection and Evaluation of Adverse Drug Reactions: Principles and Practice (Wiley-Blackwell, 2011), and, with Paul Glasziou and Les Irwig, Evidence-based Medical Monitoring: From Principles to Practice (Blackwell Publishing/BMJ Books, 2008).